RESPONSE TO TREATMENT AND VALIDATION OF NCCN-IPI IN PATIENTS DIAGNOSED WITH DIFFUSED LARGE CELL B LYMPHOMA IN AN ERA OF IMMUNOCHEMOTHERAPY

被引：0
|
作者：
Alonso Prieto, C. M. [1 ]
Garcia Ballesteros, C. [1 ]
Monzo, E. [1 ]
Lopez Martinez, A. [1 ]
Benet Campos, C. [1 ]
Bautista Claver, T. [1 ]
Mayans, J. R. [1 ]
机构：
[1] Hosp Arnau Vilanova, Serv Hematol & Hemoterapia, Valencia, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-192
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphoma
    Spiegel, Jay Y.
    Cheung, Matthew C.
    Guirguis, Hany R.
    Buckstein, Rena
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 214 - 217
  • [2] Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma
    Huang, Cih-En
    Chen, Yi-Yang
    Lu, Chang-Hsien
    Chen, Pin-Tsung
    Lee, Kuan-Der
    Chen, Chih-Cheng
    ANNALS OF HEMATOLOGY, 2015, 94 (06) : 1063 - 1065
  • [3] Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma
    Cih-En Huang
    Yi-Yang Chen
    Chang-Hsien Lu
    Pin-Tsung Chen
    Kuan-Der Lee
    Chih-Cheng Chen
    Annals of Hematology, 2015, 94 : 1063 - 1065
  • [4] Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI
    Melchardt, Thomas
    Troppan, Katharina
    Weiss, Lukas
    Hufnagl, Clemens
    Neureiter, Daniel
    Traenkenschuh, Wolfgang
    Schlick, Konstantin
    Huemer, Florian
    Deutsch, Alexander
    Neumeister, Peter
    Greil, Richard
    Pichler, Martin
    Egle, Alexander
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (12): : 1501 - 1508
  • [5] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
    Zhou, Zheng
    Sehn, Laurie H.
    Rademaker, Alfred W.
    Gordon, Leo I.
    LaCasce, Ann S.
    Crosby-Thompson, Allison
    Vanderplas, Ann
    Zelenetz, Andrew D.
    Abel, Gregory A.
    Rodriguez, Maria A.
    Nademanee, Auayporn
    Kaminski, Mark S.
    Czuczman, Myron S.
    Millenson, Michael
    Niland, Joyce
    Gascoyne, Randy D.
    Connors, Joseph M.
    Friedberg, Jonathan W.
    Winter, Jane N.
    BLOOD, 2014, 123 (06) : 837 - 842
  • [6] Prognostic prediction of diffuse large-B-cell lymphoma with International Index (IPI) and enhanced NCCN-IPI
    Zhou, Xu
    Cheng, Shidi
    Jin, Jie
    Liu, Yu
    Wang, Jin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20224 - 20230
  • [7] Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with RCHOP/R-CHOP-like in a Single Institution
    Gay, Maria Queralt Salas
    Mercadal, Santiago
    Domenech, Eva Domingo
    Oliveira, Ana C.
    Encuentra, Maite
    Climent, Fina
    Cano, Cristina Baca
    Andrade-Campos, Marcio
    De la Banda, Esmeralda
    Aguilera, Carmen
    de Sevilla, Alberto Fernandez
    Sureda, Anna
    Gonzalez-Barca, Eva
    BLOOD, 2017, 130
  • [8] International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI
    Ruppert, Amy S.
    Dixon, Jesse G.
    Salles, Gilles
    Wall, Anna
    Cunningham, David
    Poeschel, Viola
    Haioun, Corinne
    Tilly, Herve
    Ghesquieres, Herve
    Ziepert, Marita
    Flament, Jocelyne
    Flowers, Christopher
    Shi, Qian
    Schmitz, Norbert
    BLOOD, 2020, 135 (23) : 2041 - 2048
  • [9] Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution
    Queralt Salas, Maria
    Mercadal, Santiago
    Domingo Domenech, Eva
    Carla Oliveira, Ana
    Encuentra, Maite
    Climent, Fina
    Andrade Campos, Marcio
    Aguilera, Carmen
    Fernandez de Sevilla, Alberto
    Sureda, Anna
    Gonzalez-Barca, Eva
    LEUKEMIA & LYMPHOMA, 2019, : 575 - 581
  • [10] NCCN-IPI in Patients with Diffuse Large B CELL Lymphoma Treated with DA-R-EPOCH. Retrospective Analysis
    Bergua Burgues, Juan Miguel
    Lopez-Gomez, Luis
    Ibanez, Fatima
    Suarez-Varela, Sara
    Prieto-Fernandez, Julio
    Carnicero, Fernando
    Casas, Ignacio
    Martin-Mateos, Maria Luisa
    Cabrera, Carmen
    Arcos-Carmona, Maria Jose
    Banas, M. Helena
    Bermejo, Nuria
    Sanz, Miguel A.
    Bobillo-Varela, Sara
    Lopez, Andres
    BLOOD, 2016, 128 (22)
12345